Peregrine Pharmaceuticals reported $24.31M in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Adamas Pharmaceuticals ADMS:US 10.05M 57K
Amgen AMGN:US $ 4765M 286M
AstraZeneca AZN:LN 8.85B 2.01B
Biocryst Pharmaceuticals BCRX:US $ 26.21M 1.41M
Bristol Myers Squibb BMY:US $ 9245M 2030M
Celldex Therapeutics CLDX:US $ 0.2M 0.3M
Chemocentryx CCXI:US $ 20.06M 19.89M
Dicerna Pharmaceuticals DRNA:US $ 6.23M 1.21M
Eli Lilly And LLY:US $ 7025M 122.2M
Flexion Therapeutics FLXN:US $ 29.39M 5.84M
GlaxoSmithKline GSK:LN 8.28B 777M
Intrexon XON:US $ 21.08M 5.59M
Karyopharm Therapeutics KPTI:US $ 18.75M 865K
Kindred Biosciences KIN:US 1.56M 11.16M
Macrogenics MGNX:US $ 13.76M 31.49M
Mannkind MNKD:US $ 9.44M 3.14M
Newlink Genetics NLNK:US 116K 9K
Novartis NOVN:VX 8.63B 22M
Novavax NVAX:US $ 109.96M 38.6M
Repligen RGEN:US $ 122.05M 19.39M
Xencor XNCR:US $ 20.54M 5.22M